The Human Fetal Omentum: a Site of B Cell Generation
Overview
General Medicine
Authors
Affiliations
The fetal mouse omentum has been shown to be a source of precursors that exclusively reconstitutes Ly1+ B cells and the closely related Ly1- sister population, but not conventional B cells or T cells. We have extended these studies to compare B cell development in the human fetal omentum, liver, and spleen, and to demonstrate that the pro/pre-B cell compartment (CD24+, sIgM-) is detected in the omentum and liver but not spleen as early as 8 wk of gestation. From 8 to 12 wk of gestation, the proportions of IgM+ cells that were pre-B cells (cIgM+/sIgM-) in the omentum and liver were 53 +/- 15% and 45 +/- 13%, respectively, and IgM+ cells were not detectable in the spleen. After 12 wk, the percentage of pre-B cells was unchanged in the fetal liver (41 +/- 10%) but decreased significantly in the omentum (25 +/- 14%); pre-B cells were now detected in the spleen but at much lower percentages (2 +/- 3%) than either the omentum or liver. The nuclear enzyme, Tdt, was detected in approximately 25% of the CD24+ cells in the omentum and liver during the 8-12-wk time period, however, Tdt+ cells were not detected in the spleen. Approximately 40% of the mature B cells found in the omentum and spleen were CD5+ compared with only 20% in the liver. These results demonstrate that the fetal omentum, like the fetal liver and bone marrow, is a primary site of B cell development.
Yang G, Hisada A, Yamamoto M, Takatani R, Konno Y, Mori C Nutrients. 2025; 17(5).
PMID: 40077638 PMC: 11901469. DOI: 10.3390/nu17050769.
Mano Y, Igarashi Y, Komori K, Hashimoto I, Watanabe H, Takahashi K Front Immunol. 2025; 16:1521278.
PMID: 39949777 PMC: 11821591. DOI: 10.3389/fimmu.2025.1521278.
Feuer G, Briskin C, Lakhi N J Robot Surg. 2023; 17(4):1381-1391.
PMID: 36648633 DOI: 10.1007/s11701-022-01519-1.
Luo Y, Wang J, Li K, Li M, Xu S, Liu X Cell Biosci. 2022; 12(1):57.
PMID: 35526067 PMC: 9080186. DOI: 10.1186/s13578-022-00795-6.
Relevance of the Materno-Fetal Interface for the Induction of Antigen-Specific Immune Tolerance.
Mimoun A, Delignat S, Peyron I, Daventure V, Lecerf M, Dimitrov J Front Immunol. 2020; 11:810.
PMID: 32477339 PMC: 7240014. DOI: 10.3389/fimmu.2020.00810.